Plasma proteomics for biomarker discovery in childhood tuberculosis.
Saved in:
| Title: | Plasma proteomics for biomarker discovery in childhood tuberculosis. |
|---|---|
| Authors: | Fossati A; J. David Gladstone Institutes, San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Wambi P; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kololo, Kampala, Uganda., Jaganath D; Institute for Global Health Sciences, Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of California San Francisco, San Francisco, CA, USA., Calderon R; Advanced Research and Health, Lima, Peru., Castro R; Institute for Global Health Sciences, Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.; Department of Medicine, Division of Pulmonary and Critical Care Medicine, University of California San Francisco, San Francisco, CA, USA., Mohapatra A; Institute for Global Health Sciences, Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.; Department of Medicine, Division of Experimental Medicine, University of California San Francisco, San Francisco, California, CA, USA., McKetney J; J. David Gladstone Institutes, San Francisco, CA, USA.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA., Luiz J; Department of Pediatrics and Child Health, South African Medical Research Council Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa.; Department of Pediatrics, Dora Nginza Hospital, Gqeberha, South Africa., Nerurkar R; Institute for Global Health Sciences, Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.; Department of Pediatrics, Division of Pediatric Infectious Diseases, University of California San Francisco, San Francisco, CA, USA., Nkereuwem E; Vaccines and Immunity Theme, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia., Franke MF; Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA., Mousavian Z; Division of Infectious Diseases, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden.; Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA., Collins JM; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA., Sigal GB; Meso Scale Diagnostics, LLC., Rockville, MD, USA., Segal MR; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA., Kampman B; Vaccines and Immunity Theme, MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Fajara, The Gambia.; Charité Center for Global Health, Charité Universitätsmedizin Berlin, Berlin, Germany., Wobudeya E; Uganda Tuberculosis Implementation Research Consortium, Walimu, Kololo, Kampala, Uganda., Cattamanchi A; Institute for Global Health Sciences, Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.; Division of Pulmonary Diseases and Critical Care Medicine, Department of Medicine, University of California Irvine, Irvine, CA, USA., Ernst JD; Institute for Global Health Sciences, Center for Tuberculosis, University of California San Francisco, San Francisco, CA, USA.; Department of Medicine, Division of Experimental Medicine, University of California San Francisco, San Francisco, California, CA, USA., Zar HJ; Department of Pediatrics and Child Health, South African Medical Research Council Unit on Child and Adolescent Health, University of Cape Town, Cape Town, South Africa. heather.zar@uct.ac.za., Swaney DL; J. David Gladstone Institutes, San Francisco, CA, USA. danielle.swaney@ucsf.edu.; Quantitative Biosciences Institute (QBI), University of California San Francisco, San Francisco, CA, USA. danielle.swaney@ucsf.edu.; Department of Cellular and Molecular Pharmacology, University of California San Francisco, San Francisco, CA, USA. danielle.swaney@ucsf.edu. |
| Corporate Authors: | COMBO Study Consortium |
| Source: | Nature communications [Nat Commun] 2025 Jul 19; Vol. 16 (1), pp. 6657. Date of Electronic Publication: 2025 Jul 19. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2041-1723 |
|---|---|
| DOI: | 10.1038/s41467-025-61515-5 |
